Scaramuzza, S., Biasco, L., Ripamonti, A., Castiello, M. C., Loperfido, M., Draghici, E., . . . Aiuti, A. (2013). Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome. Nature Publishing Group.
Παραπομπή Chicago StyleScaramuzza, Samantha, et al. Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome. Nature Publishing Group, 2013.
Παραπομπή MLAScaramuzza, Samantha, et al. Preclinical Safety and Efficacy of Human CD34(+) Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome. Nature Publishing Group, 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.